ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

KALV KalVista Pharmaceuticals Inc

12.13
-0.04 (-0.33%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
KalVista Pharmaceuticals Inc KALV NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.04 -0.33% 12.13 05:35:11
始値 安値 高値 終値 前日終値
12.24 11.955 12.48 12.13 12.17
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0219:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
2024/5/0119:30BWKalVista Pharmaceuticals Highlights Strategic Plans for..
2024/4/2219:30BWKalVista Pharmaceuticals Appoints William C. Fairey to Board..
2024/4/0319:30BWKalVista Pharmaceuticals to Present at 23rd Annual Needham..
2024/4/0219:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
2024/3/1819:30BWKalVista Pharmaceuticals Presents Real-World Data on Burden..
2024/3/1219:30BWKalVista Pharmaceuticals Awarded UK Promising Innovative..
2024/3/1205:37EDGAR2Form 8-K - Current report
2024/3/1205:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/3/1119:30BWKalVista Pharmaceuticals Reports Third Fiscal Quarter..
2024/3/0906:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0820:30BWKalVista Pharmaceuticals to Present HAE Attack Journey Data..
2024/3/0720:38EDGAR2Form 8-K - Current report
2024/3/0720:30BWKalVista Pharmaceuticals Announces Appointment of Benjamin..
2024/3/0620:30BWKalVista Pharmaceuticals to Participate in the Leerink..
2024/3/0420:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
2024/2/2720:30BWKalVista Pharmaceuticals Presents Data on Unmet Needs in HAE..
2024/2/2620:30BWKalVista Pharmaceuticals Presents Additional Phase 3..
2024/2/2306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2303:22EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/2/2211:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:49EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/2/2020:30BWKalVista Pharmaceuticals Awarded UK Innovation Passport for..
2024/2/1706:32EDGAR2Form 8-K - Current report
2024/2/1706:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/1706:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1620:30BWKalVista Pharmaceuticals to Present Phase 3 Sebetralstat..
2024/2/1520:30BWKalVista Pharmaceuticals Announces Pricing of a $160.1..
2024/2/1510:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1507:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/1506:18BWKalVista Pharmaceuticals Announces Proposed Public Offering..
2024/2/1506:14EDGAR2Form 8-K - Current report
2024/2/1323:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1323:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1320:55EDGAR2Form 8-K - Current report
2024/2/1320:30BWKalVista Pharmaceuticals Reports Phase 3 KONFIDENT Trial..
2024/2/1310:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0910:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0607:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0220:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..

最近閲覧した銘柄

Delayed Upgrade Clock